Amesite (AMST) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
26 May, 2026Risk factors and disclosures
Auditors included a going concern explanatory paragraph in the latest audit, highlighting uncertainty about the company's ability to continue operations without additional capital or improved financial performance.
Indemnification agreements and liability insurance are in place for directors and officers, with provisions for advancement of expenses and reimbursement if indemnification is found unwarranted.
Indemnification for liabilities under the Securities Act may be unenforceable if deemed against public policy, and any such claims will be subject to court adjudication.
Management team and governance
CEO, President, and Chairman roles are held by Ann Marie Sastry, Ph.D., with Sarah Berman as Principal Financial and Accounting Officer.
Board includes directors Barbie Brewer, Michael Losh, Gilbert S. Omenn, M.D., Ph.D., and George Parmer.
Offering details and pricing
Registration statement filed as an amendment to correct a technical error in auditor consent; offering to commence as soon as practicable after effectiveness.
Estimated offering expenses (excluding underwriting discounts/commissions) total $60,674.56, including SEC, accounting, legal, and miscellaneous fees.
Latest events from Amesite
- Revenue increased and net loss narrowed, but going concern risks persist despite new capital.AMST
Q3 202618 May 2026 - AI healthcare firm offers 4.8M shares for resale, with viability dependent on warrant exercise proceeds.AMST
Registration filing12 May 2026 - Healthcare AI firm offers shares and warrants to fund growth amid ongoing losses and compliance risks.AMST
Registration filing20 Apr 2026 - NurseMagic™ app drives rapid revenue growth and market adoption in healthcare AI.AMST
Investor presentation6 Feb 2026 - NurseMagic's rapid adoption and scalable AI platform drive strong revenue and market growth.AMST
Investor presentation6 Feb 2026 - Revenue surged but losses persist; going concern and Nasdaq compliance risks remain.AMST
Q2 20266 Feb 2026 - Director and auditor approved; NurseMagic gains traction; strong insider investment.AMST
AGM 202510 Jan 2026 - NurseMagic's rapid adoption and scalable sales model position the company for profitable growth in 2025.AMST
Sidoti Micro-Cap Virtual Conference9 Jan 2026 - Flexible $100M shelf registration targets growth in AI-driven education and healthcare solutions.AMST
Registration Filing16 Dec 2025